Koninklijke Philips N.V.

Philips is a Dutch multinational that focuses on health technology and personal well‑being, offering products and services that range from diagnostic imaging systems, patient monitoring equipment and ultrasound devices to image‑guided therapy platforms and health informatics solutions. In the consumer sphere the company provides personal care items such as electric toothbrushes, shavers and mother‑and‑child care products, while its historic lighting business has been separated into a distinct entity. These offerings are directed at hospitals, clinics, healthcare providers and individual consumers across a variety of markets.

The company maintains a substantial global footprint, conducting operations in more than one hundred countries and employing tens of thousands of staff worldwide. Its presence spans Europe, North America, Asia‑Pacific and other regions, allowing it to serve a diverse set of customers and adapt its solutions to local regulatory and clinical environments. This extensive reach is supported by a network of research centres, manufacturing sites and service organisations that enable Philips to develop, produce and support its technologies on an international scale.

Philips distinguishes itself through a strong emphasis on healthcare innovation, investing heavily in research and development to advance medical imaging, clinical informatics and connected care solutions. The firm is recognised for its leadership in diagnostic imaging modalities such as MRI, CT and ultrasound, and it often collaborates with healthcare institutions to co‑create technologies that meet stringent regulatory standards. Its competencies also extend to integrating hardware with software and data analytics, aiming to improve patient outcomes and operational efficiency for providers.

Structurally, Philips is a publicly traded company with shares listed on both Euronext Amsterdam and the New York Stock Exchange, and it does not operate under a larger parent corporation. The organisation’s governance includes a board of directors and an executive committee responsible for overseeing its strategic direction across the health technology and personal care segments. This ownership structure enables Philips to access capital markets while maintaining autonomy over its business decisions and long‑term investment priorities.